Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-09-005823
Filing Date
2009-03-04
Accepted
2009-03-04 15:06:13
Documents
1
Period of Report
2009-03-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3718
  Complete submission text file 0001127602-09-005823.txt   5511
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 205-444-4607
Grant Stuart (Reporting) CIK: 0001410397 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 09655180